Royal Liver is joining up with Marlborough Stirling ahead of its launch into the IFA market in the UK.
Under a ten year contract Marlborough will offer Royal Liver its electronic quotation and new business transaction services via the Exweb portal.
It will also use 'Lamda' Marlborough's new business processing solution, that allows straight through processing from Exweb to back office administration, including automated underwriting and acceptance of the majority of new business cases.
The arrangements are expected to generate at least £25 million in turnover for Marlborough Stirling over the 10 year contract period.
Marlborough Stirling group development director Chris Ryland says: “We are delighted to have been selected as Royal Liver's partner for its launch into the IFA market. This initiative is a clear endorsement of our strategy of assembling the solutions to deliver tightly integrated end-to-end e-commerce services to the industry for the first time.”